Coforge Limited delivered a mixed operational performance in Q3FY26, missing revenue and profitability estimates, yet reinforcing its long-term investment thesis through a sharply expanding order b
News in Focus


DLF's Q3FY26 performance may appear underwhelming at first glance, but a deeper examination suggests that the company’s long-term growth trajectory remains firmly intact.

Axis Securities has reiterated its BUY call on Kotak Mahindra Bank Limited, assigning a target price of Rs 515, implying an upside of 22% from current levels.

Indian Bank’s Q3FY26 performance underscores a phase of measured consolidation rather than aggressive expansion.

Dr Reddy’s Laboratories is navigating a critical transition phase as legacy gains from gRevlimid taper off, even as the company lays the groundwork for its next multi-year growth cycle.

UltraTech Cement, India’s largest cement manufacturer, continues to outpace industry growth as capacity expansion, operational efficiencies, and infrastructure-led demand converge into a multi-year
Main Regional Stories

Gujarat Themis Biosyn Limited (GTBL), a niche pharmaceutical manufacturer specializing in fermentation-based intermediates, is entering a decisive phase of strategic evolution. BP Equities Pvt. Ltd.

Motilal Oswal Financial Services has reiterated a BUY call on Suzlon Energy, arguing that the recent correction in the stock has created a compelling risk-reward setup at a time when India’s renewable energy architecture is quietly re-tilting in f

ICICI Direct has reiterated its BUY recommendation on SRF Limited, setting a 12-month target price of Rs 3,315, implying an upside of 21 percent from current levels.

Cyient DLM Limited’s Q3FY26 performance reflected a transitional phase rather than a deterioration in business fundamentals.
Bollywood’s newest heart-throbs and star kids, Sonam Kapoor and Ranbir Kapoor, have been a
New York: A study has revealed that first three hours at the start of stroke are significant for th








